Literature DB >> 17484878

The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury.

Wenlin Deng1, E Shuyu, Ryoko Tsukahara, William J Valentine, Gangadhar Durgam, Veeresa Gududuru, Louisa Balazs, Venkatraman Manickam, Marcello Arsura, Lester VanMiddlesworth, Leonard R Johnson, Abby L Parrill, Duane D Miller, Gabor Tigyi.   

Abstract

BACKGROUND & AIMS: We recently identified lysophosphatidic acid (LPA) as a potent antiapoptotic agent for the intestinal epithelium. The objective of the present study was to evaluate the effect of octadecenyl thiophosphate (OTP), a novel rationally designed, metabolically stabilized LPA mimic, on radiation-induced apoptosis of intestinal epithelial cells in vitro and in vivo.
METHODS: The receptors and signaling pathways activated by OTP were examined in IEC-6 and RH7777 cell lines and wild-type and LPA(1) and LPA(2) knockout mice exposed to different apoptotic stimuli.
RESULTS: OTP was more efficacious than LPA in reducing gamma irradiation-, camptothecin-, or tumor necrosis factor alpha/cycloheximide-induced apoptosis and caspase-3-8, and caspase-9 activity in the IEC-6 cell line. In RH7777 cells lacking LPA receptors, OTP selectively protected LPA(2) but not LPA(1) and LPA(3) transfectants. In C57BL/6 and LPA(1) knockout mice exposed to 15 Gy gamma irradiation, orally applied OTP reduced the number of apoptotic bodies and activated caspase-3-positive cells but was ineffective in LPA(2) knockout mice. OTP, with higher efficacy than LPA, enhanced intestinal crypt survival in C57BL/6 mice but was without any effect in LPA(2) knockout mice. Intraperitoneally administered OTP reduced death caused by lethal dose (LD)(100/30) radiation by 50%.
CONCLUSIONS: Our data indicate that OTP is a highly effective antiapoptotic agent that engages similar prosurvival pathways to LPA through the LPA(2) receptor subtype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484878      PMCID: PMC3446791          DOI: 10.1053/j.gastro.2007.03.038

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  56 in total

1.  Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine.

Authors:  Christopher S Potten
Journal:  Radiat Res       Date:  2004-02       Impact factor: 2.841

2.  GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.

Authors:  Chang-Wook Lee; Richard Rivera; Shannon Gardell; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

3.  Transbilayer movement and metabolic fate of ether-linked phosphatidic acid (1-O-Octadecyl-2-acetyl-sn-glycerol 3-phosphate) in guinea pig peritoneal polymorphonuclear leukocytes.

Authors:  A Tokumura; T Tsutsumi; H Tsukatani
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

4.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

Authors:  J J Contos; N Fukushima; J A Weiner; D Kaushal; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

5.  c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration.

Authors:  Yun-Ju Lai; Chen-Shan Chen; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

6.  Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level.

Authors:  Junming Yue; Kazuaki Yokoyama; Louisa Balazs; Daniel L Baker; David Smalley; Carlos Pilquil; David N Brindley; Gabor Tigyi
Journal:  Cell Signal       Date:  2004-03       Impact factor: 4.315

7.  The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.

Authors:  F Chu; A Borthakur; X Sun; J Barkinge; R Gudi; S Hawkins; K V S Prasad
Journal:  Apoptosis       Date:  2004-01       Impact factor: 4.677

8.  Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.

Authors:  Chia-Hung Chou; Lin-Hung Wei; Min-Liang Kuo; Yun-Ju Huang; Kuo-Pao Lai; Chi-An Chen; Chang-Yao Hsieh
Journal:  Carcinogenesis       Date:  2004-10-07       Impact factor: 4.944

9.  Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.

Authors:  D J Fischer; K Liliom; Z Guo; N Nusser; T Virág; K Murakami-Murofushi; S Kobayashi; J R Erickson; G Sun; D D Miller; G Tigyi
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

Review 10.  Lysophospholipid receptors: signaling and biology.

Authors:  Isao Ishii; Nobuyuki Fukushima; Xiaoqin Ye; Jerold Chun
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

View more
  53 in total

1.  The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.

Authors:  Songbai Lin; Sei-Jung Lee; Hyunsuk Shim; Jerold Chun; C Chris Yun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

Review 2.  Radiation enteropathy--pathogenesis, treatment and prevention.

Authors:  Martin Hauer-Jensen; James W Denham; H Jervoise N Andreyev
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-01       Impact factor: 46.802

3.  Identification of non-lipid LPA3 antagonists by virtual screening.

Authors:  James I Fells; Ryoko Tsukahara; Yuko Fujiwara; Jianxiong Liu; Donna H Perygin; Daniel A Osborne; Gabor Tigyi; Abby L Parrill
Journal:  Bioorg Med Chem       Date:  2008-04-18       Impact factor: 3.641

4.  Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.

Authors:  Shannon K Oda; Pamela Strauch; Yuko Fujiwara; Amin Al-Shami; Tamas Oravecz; Gabor Tigyi; Roberta Pelanda; Raul M Torres
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

Review 5.  Lipid phosphate phosphatases and their roles in mammalian physiology and pathology.

Authors:  Xiaoyun Tang; Matthew G K Benesch; David N Brindley
Journal:  J Lipid Res       Date:  2015-03-26       Impact factor: 5.922

6.  Role of phospholipids in protection of the GI mucosa.

Authors:  Lenard M Lichtenberger
Journal:  Dig Dis Sci       Date:  2013-04       Impact factor: 3.199

7.  Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.

Authors:  Shuyu E; Yun-Ju Lai; Ryoko Tsukahara; Chen-Shan Chen; Yuko Fujiwara; Junming Yue; Jei-Hwa Yu; Huazhang Guo; Akio Kihara; Gábor Tigyi; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

Review 8.  Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer.

Authors:  Glenn D Prestwich; Joanna Gajewiak; Honglu Zhang; Xiaoyu Xu; Guanghui Yang; Monica Serban
Journal:  Biochim Biophys Acta       Date:  2008-04-08

9.  Synthesis, pharmacology, and cell biology of sn-2-aminooxy analogues of lysophosphatidic acid.

Authors:  Joanna Gajewiak; Ryoko Tsukahara; Yuko Fujiwara; Gabor Tigyi; Glenn D Prestwich
Journal:  Org Lett       Date:  2008-02-20       Impact factor: 6.005

Review 10.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.